Multiphoton microscopy is a valuable tool for neuroscience research, allowing scientists to observe functional brain activity ...

Hyperfine (Nasdaq:HYPR) enrolled the initial patients in a study of its portable MRI technology for neurological evaluation.

US global pharma sector has been in a state of relaxed wooziness since Donald Trump’s U-turn on some punitive country tariffs last week.

Medtech companies such as Siemens Healthineers, Philips and GE HealthCare sell movable MRIs that can fit inside trailers.

Hubballi: Karnataka Medical College-Research Institute (KMC-RI) is facing a severe shortage of MRI machines, forcing many patients to wait in a long queue for scans. The hospital receives 75 to ...

Tom Nolan reviews this week’s research There are so many studies published about vitamin D—about a dozen each day—it’s hard to keep up. One that stands out is a double-blind randomised controlled ...

Evidence for chemotherapy-induced cognitive changes comes from studies that have used neuropsychological testing, imaging (structural and functional magnetic resonance imaging (MRI) and positron ...

The standard mammogram is sometimes used with breast magnetic resonance imaging ... MRI techniques that don't rely on contrast continue to evolve. Still, the U.S. Food and Drug Administration issued a ...

Key Laboratory of Theoretical Organic Chemistry and Function Molecule, Ministry of Education, School of Chemistry and Chemical Engineering, Hunan University of Science and Technology, Xiangtan, Hunan ...

Full-body scans use different technologies, including magnetic resonance imaging (MRI), computed ... has not recommended that any of his patients get an MRI screening scan. "The high upfront ...

costing patients up to 40% more in out-of-pocket costs. A legally required letter was sent from Regence to its members warning of the potential contract impasse. “I was pretty shocked by that ...

The initiative is aimed at considerably reducing the cost of Magnetic Resonance Imaging (MRI ... norms for validating MRI scanners to give clearance to use it on patients, even during trials.